Showing CypComp Card for CC02066: Voreloxin (CypBoM Training Set)

Record Information
Version1.0
Creation Date2019-07-14 16:36:39 UTC
Last Updated2019-10-01 21:41:22 UTC
CypComp IDCC02066
Compound Information
NameVoreloxin
Structure ImageXzafzxjxzhrnaq chwsqxevsa n
InChIKeyXZAFZXJXZHRNAQ-CHWSQXEVSA-N
PubChem ID9865776
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <8,9;Reduction;R1>
  • <28,27;Cleavage;R2>
  • <28,H;Oxidation;R2>
  • <26,25;Cleavage;R3>
  • <26,H;Oxidation;R3>
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <8,9;Reduction;R1>
  • Not Available
  • <8,9;Reduction;R1>
  • <28,27;Cleavage;R2>
  • <28,H;Oxidation;R2>
  • <26,25;Cleavage;R3>
  • <26,H;Oxidation;R3>
References
  1. Evanchik MJ, Allen D, Yoburn JC, Silverman JA, Hoch U: Metabolism of (+)-1,4-dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiaz olyl)-1,8-naphthyridine-3-carboxylic acid (voreloxin; formerly SNS-595), a novel replication-dependent DNA-damaging agent. Drug Metab Dispos. 2009 Mar;37(3):594-601. doi: 10.1124/dmd.108.023432. Epub 2008 Dec 12. [PubMed:19074528 ]
Download FileCC02066.sdf